Pith. sign in

REVIEW

Optimal medication for tumors modeled by a Cahn-Hilliard-Brinkman equation

Not yet reviewed by Pith; the record is open.

This paper has not been read by Pith yet. Machine review is queued; the pith claim, tier, and objections will appear here once it completes.

SPECIMEN: schema-true, not a live event

T0 review · schema-true

One-sentence machine reading of the paper's core claim.

pith:XXXXXXXX · record.json · timestamp

arxiv 1811.07783 v3 pith:YA4JLBLU submitted 2018-11-19 math.OC math.AP

classification math.OCmath.AP
keywords equationboundaryconditionscontrolmodeloptimaltumortype
verification ladder T0 review T1 audit T2 compute T3 formal

Signed reviews

No signed human review yet.

0 comments
read the original abstract

In this paper, we study a distributed optimal control problem for a diffuse interface model for tumor growth. The model consists of a Cahn-Hilliard type equation for the phase field variable coupled to a reaction diffusion equation for the nutrient and a Brinkman type equation for the velocity. The system is equipped with homogeneous Neumann boundary conditions for the tumor variable and the chemical potential, Robin boundary conditions for the nutrient and a "no-friction" boundary condition for the velocity. The control acts as a medication by cytotoxic drugs and enters the phase field equation. The cost functional is of standard tracking type and is designed to track the variables of the state equation during the evolution and the distribution of tumor cells at some fixed final time. We prove that the model satisfies the basics for calculus of variations and we establish first-order necessary optimality conditions for the optimal control problem.

Discussion (0). Continue with ORCID to comment.

Pith tools